Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.34M | -3.99M | -3.70M | -3.56M | -4.15M |
| Total Depreciation and Amortization | 5.70K | 8.00K | 6.50K | 7.70K | 8.80K |
| Total Amortization of Deferred Charges | 856.50K | 1.33M | 1.24M | 1.33M | 2.04M |
| Total Other Non-Cash Items | 341.30K | 344.50K | 86.90K | -121.70K | -137.50K |
| Change in Net Operating Assets | 1.26M | 1.60M | 1.46M | 1.29M | 850.10K |
| Cash from Operations | -872.40K | -710.10K | -910.30K | -1.06M | -1.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 987.90K | 881.90K | 985.40K | 786.80K | 1.39M |
| Total Debt Repaid | -115.00K | -71.60K | -45.00K | -20.00K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -5.50K |
| Cash from Financing | 873.00K | 810.40K | 940.40K | 766.80K | 1.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 400.00 | 100.10K | 30.00K | -289.50K | 3.40K |